vebicorvir

Assembly Bio scraps hepatitis B drug, cuts staff after clinical setback
BioPharma Dive
Thu, 07/21/22 - 09:54 pm
Assembly Biosciences
hepatitis B
layoffs
vebicorvir
Assembly Bio's hepatitis B program flops as a potential cure in PhII, sending shares spiraling
Endpoints
Sat, 11/7/20 - 11:06 pm
Assembly Biosciences
hepatitis B
clinical trials
vebicorvir